OpenAI takes the lead in AI IPO horse race: 'Getting to public markets first is very important'

OpenAI is reported to be preparing a confidential IPO filing as soon as Friday, lifting its odds of going public before Anthropic to 83% on Kalshi, while Anthropic's probability dropped to 20% on Polymarket. The move improves OpenAI's market narrative, but investor concerns remain around spending, missed revenue/growth targets, and leadership turnover. Anthropic remains highly valued, with reports of a potential new round at a $900 billion valuation, while OpenAI's filing could set an early benchmark for AI listings.

Analysis

The market is treating IPO timing as a relative-strength signal, but the bigger implication is governance and capital-access optionality. A near-term filing would likely reset private-market pricing across frontier AI, compressing the “scarcity premium” that has supported late-stage rounds and secondary demand; that helps the first mover but can hurt the second mover by forcing it to defend valuation on less favorable terms. In practice, the public-market process itself becomes a recruiting and enterprise-sales tool, so the winner is not just the company that lists first, but the one that can convert listing momentum into lower CAC, better talent retention, and cheaper compute financing over the next 6-12 months.

The key second-order trade is that an IPO does not eliminate execution risk; it surfaces it. Once public, any deceleration in growth, margin pressure from inference costs, or governance friction around strategy can re-rate the stock quickly because investors will anchor to quarterly cadence rather than narrative optionality. That creates a setup where the first listing may pop on scarcity, but the post-lockup and first 2-3 earnings windows are where the business model gets repriced. For competitors, the signaling effect is mixed: enterprise buyers may prefer the “most durable” platform, but price-sensitive customers and developers will likely shop harder for multi-model flexibility if public scrutiny forces a more aggressive monetization path.

The contrarian view is that first-to-market may be less valuable than investors think if the public debut becomes a valuation ceiling rather than a catalyst. A very rich opening market cap can actually constrain strategic flexibility, especially if management needs to fund compute at scale without disappointing public holders. If the market decides one company is the cleaner enterprise monetization story and the other is the cleaner consumer brand, the initial IPO premium could unwind into a relative-value trade rather than a simple winner-take-all outcome.

Key Decisions for Investors

• Prepare a relative-value short/long basket: long the company that files first on IPO-day momentum, short the eventual second filer on a 1-3 month horizon. The thesis is scarcity premium plus index/research coverage flow; risk is a superior filing deck or stronger demand from the second name.
• If direct access exists, buy post-IPO call spreads on the first AI listing into the filing/price-range window, then monetize into the first two weeks of trading. Risk/reward is favorable because IPO supply constraints can drive a temporary squeeze, but upside should be capped by valuation scrutiny.
• Use listed AI beneficiaries as a hedge against private AI disappointment: long NVDA into any post-filing dip if the market interprets the IPO as evidence of durable compute demand. Time horizon 3-12 months; risk is multiple compression if capex growth slows.
• Fade the hype by shorting late-stage private AI secondary proxies or venture/growth baskets if available after the filing. The trade benefits if public-market transparency re-prices unprofitable growth and tightens private funding terms over the next 1-2 quarters.
• Set a catalyst watch on the first earnings cycle after IPO: if revenue growth or gross margin miss expectations, take profits aggressively on any initial pop. The main risk is that the IPO itself becomes a multiple-expansion event that lasts longer than the first quarter.